Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Assets Average (2018 - 2025)

Historic Assets Average for Crinetics Pharmaceuticals (CRNX) over the last 8 years, with Q3 2025 value amounting to $1.2 billion.

  • Crinetics Pharmaceuticals' Assets Average rose 3271.36% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 3271.36%. This contributed to the annual value of $1.0 billion for FY2024, which is 10960.85% up from last year.
  • According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' Assets Average is $1.2 billion, which was up 3271.36% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Crinetics Pharmaceuticals' Assets Average peaked at $1.4 billion during Q1 2025, and registered a low of $173.5 million during Q1 2021.
  • In the last 5 years, Crinetics Pharmaceuticals' Assets Average had a median value of $403.3 million in 2022 and averaged $628.6 million.
  • In the last 5 years, Crinetics Pharmaceuticals' Assets Average plummeted by 1956.98% in 2023 and then surged by 21513.33% in 2024.
  • Over the past 5 years, Crinetics Pharmaceuticals' Assets Average (Quarter) stood at $280.2 million in 2021, then surged by 31.53% to $368.5 million in 2022, then skyrocketed by 73.24% to $638.4 million in 2023, then skyrocketed by 85.76% to $1.2 billion in 2024, then rose by 4.79% to $1.2 billion in 2025.
  • Its last three reported values are $1.2 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.4 billion during Q1 2025.